Circulatory Management and Acute Kidney Injury in Patients Undergoing Partial Nephrectomy
Acute Kidney Injury
About this trial
This is an interventional prevention trial for Acute Kidney Injury focused on measuring partial nephrectomy, acute kidney injury, LiDCOrapid, circulatory management
Eligibility Criteria
Inclusion Criteria:
- Age > 18 years;
- Planning to undergo partial nephrectomy;
Exclusion Criteria:
- Patients with renal function damage (chronic kidney disease stage 3-5) before surgery;
- Patients with arrhythmia or aortic valve diseases (moderate or higher degree stenosis/regurgitation);
- Patients who has participated in other trials.
Sites / Locations
- Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention group
Control group
In addition to routine monitoring, invasive LiDCOrapid is used to monitor mean arterial pressure (MAP), stroke volume variation (SVV) and cardiac index (CI). Intraoperative goal-directed circulatory management is performed, i.e., to maintain MAP > 95 mmHg, SVV < 6%, and CI 3.0-4.0 L/min/m2, started from renal artery clamping and maintained until the end of surgery.
Routine monitoring is performed, which includes invasive blood pressure and urine output. Intraoperative routine circulatory management is performed, i.e., to maintain blood pressure within 20% from baseline level and urine output > 0.5 ml/kg/h.